<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17">
 <label>17.</label>
 <element-citation publication-type="other">
  <article-title>Gilead Announces Results from Phase 3 Trial of Investigational Antiviral Remdesivir in Patients with Severe COVID-19 [news release].</article-title>
  <comment>Foster City, CA; April 29, 2020: Gilead Sciences</comment>
 </element-citation>
</ref>
